Interaction of GABA and glutamate in the horizontal limb of diagonal band of Broca (hDB): role in cardiovascular responses.
The diagonal band of Broca (DBB) is a part of the limbic system that consists of two parts: the vertical limb (vDB) and the horizontal limb (hDB). It has been shown that microinjection of glutamate into the hDB of the anesthetized rat elicited depressor responses. We have previously shown that microinjection of AP5 (an NMDA receptor antagonist, 2.5 mM, 50 nl) and CNQX (an AMPA receptor antagonist, 1 mM, 50 nl) caused no significant changes in the blood pressure and heart rate. Microinjection of bicuculline (BMI: a GABA(A) receptor antagonist, 1 mM, 50 nl) resulted in the increase of both the blood pressure and heart rate. In this study, we investigated the possible interaction of the GABAergic and glutaminergic systems of the hDB by coinjection of the antagonists of both systems. Experiments were performed on the 24 urethane-anesthetized rats. Repeated measures ANOVA was used for data analysis. Our results showed that coinjection of 50 nl of 1 mM of BMI and 2.5 mM of AP5 significantly (ANOVA, P < 0. 01) decreased the pressor effects of BMI. Also, coinjection of 50 nl of BMI (1 mM) and CNQX (1 mM) significantly (ANOVA, P < 0.01) decreased the pressor effects of BMI. Coinjection of the previous amounts of BMI and both of the glutamate receptor antagonists also produced the same results. These results showed that the cardiovascular effects of blockade of GABAergic inhibition in the hDB are dependent on the activation of local NMDA and non-NMDA receptors of glutamate. A possible interpretation of the results is that, the GABAergic neurons inhibit the glutaminergic neurons.
Hatam
Masoumeh
M
Department of Physiology, Bandar-Abbas University of Medical Sciences, Bandar-Abbas, Iran.
Nasimi
Ali
A
D015763:2-Amino-5-phosphonovalerate / Q000008:administration & dosage; D018750:6-Cyano-7-nitroquinoxaline-2,3-dione / Q000008:administration & dosage; D000704:Analysis of Variance; D000818:Animals; D001640:Bicuculline / Q000008:administration & dosage; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology*; D020667:Diagonal Band of Broca / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D004347:Drug Interactions; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage; D018756:GABA Antagonists / Q000008:administration & dosage; D018698:Glutamic Acid / Q000502:physiology*; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology*; D008297:Male; D008845:Microinjections; D009433:Neural Inhibition / Q000502:physiology; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D018079:Receptors, GABA / Q000187:drug effects / Q000502:physiology; D017470:Receptors, Glutamate / Q000187:drug effects / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D018691:Excitatory Amino Acid Antagonists; D018756:GABA Antagonists; D018079:Receptors, GABA; D017470:Receptors, Glutamate; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D018750:6-Cyano-7-nitroquinoxaline-2,3-dione; D015763:2-Amino-5-phosphonovalerate; D001640:Bicuculline